GSK Plans New Solid Dosage Mfg Plant in India
GSK India, part of GlaxoSmithKline (GSK), has started work a new Rs. 1000 crore ($154 million) pharmaceutical solid dosage manufacturing facility in Vemgal, Karnataka, India. When fully operational in 2017, the factory will make more than 8 billion tablets and 1 billion capsules in the areas of gastroenterology and anti-inflammatory medicines for the Indian market.
The facility will be built on a 50-acre site in Vemgal, Karnataka. The factory is expected to employ 300 people once in operation.
The factory will be built in partnership with international and local design and construction companies. The facility will also include a warehouse, site infrastructure, employee welfare center, and utilities to support the manufacturing and packing of the medicines.
Source: GSK India